Literature DB >> 22067545

Deep venous thrombosis in acute stroke patients.

Jan P Bembenek1, Michał Karlinski, Adam Kobayashi, Anna Czlonkowska.   

Abstract

Deep venous thrombosis (DVT) is a complication of stroke. Our aim was to determine the frequency of DVT in patients with acute stroke, risk factors for its development, and its influence on the 3-month outcome. A total of 323 consecutive patients with acute stroke were enrolled. We performed ultrasound imaging within 7 days after stroke. Deep venous thrombosis was found in 8.7% of patients, only in those with ischemic stroke. Patients with DVT were more frequently female (71.4% vs 49.5%), had prestroke Modified Rankin scale (mRS) 3 to 5 (42.9% vs 15.3%), elevated C-reactive protein (CRP) serum level (65.4% vs 32.5%), and a trend toward elevated serum fibrinogen level (85.7% vs 70.1%; P = .08). In a multivariate analysis, elevated CRP (odds ratio [OR] 3.15) and prestroke disability (OR 2.89) were independent risk factors for DVT. Deep venous thrombosis occurs in <10% of patients with acute stroke and does not significantly affect the 3-month outcome. Prestroke dependency and elevated CRP level at baseline are independent risk factors for DVT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22067545     DOI: 10.1177/1076029611424575

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  High Plasma Levels of D-Dimer Are Independently Associated with a Heightened Risk of Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage.

Authors:  Xuan Cheng; Lu Zhang; Nan-Chang Xie; Yun-Qing Ma; Ya-Jun Lian
Journal:  Mol Neurobiol       Date:  2015-10-21       Impact factor: 5.590

2.  Risk Factors for DVT/PE in Patients with Stroke and Intracranial Hemorrhage.

Authors:  Mark Stecker; Kathleen Michel; Karin Antaky; Sarah Cherian; Feliks Koyfmann
Journal:  Open Neurol J       Date:  2014-04-04

3.  Clinical Risk Factors of Asymptomatic Deep Venous Thrombosis in Patients With Acute Stroke.

Authors:  Yi Wang; Yu Shi; Yi Dong; Qiang Dong; Ting Ye; Kun Fang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

4.  A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function.

Authors:  Jean E M Ramirez; Ahmed B Alarabi; Fadi T Khasawneh; Fatima Z Alshbool
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

5.  Leukocyte as an Independent Predictor of Lower-Extremity Deep Venous Thrombosis in Elderly Patients With Primary Intracerebral Hemorrhage.

Authors:  Gang Wang; Wenjun Zhao; Zhiyong Zhao; Dengfeng Wang; Dong Wang; Ruobing Bai; Boru Hou; Haijun Ren
Journal:  Front Neurol       Date:  2022-07-12       Impact factor: 4.086

6.  The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function.

Authors:  Olivia A Lin; Zubair A Karim; Hari Priya Vemana; Enma V P Espinosa; Fadi T Khasawneh
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

7.  Deep Vein Thrombosis in the Lower Extremities in Comatose Elderly Patients with Acute Neurological Diseases.

Authors:  Shoko Merrit Yamada; Yusuke Tomita; Hideki Murakami; Makoto Nakane
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.